Dosage and Administration Saxenda is administered via subcutaneous injection, typically once a day. The dosage may vary depending on individual health factors and the desired weight loss goals.

A Blue Cross Blue Shield study of one decade worth of claims for Saxenda and Wegovy found 58% of patients quit the weight-loss drugs after 12 weeks.

If added, liraglutide will be the first weight-loss medication to make the Essential Medicines List, making way for other weight-loss drugs like newer and more potent drug Wegovy.

There are also several side effects associated with the weight loss drug that can be quite severe. The Saxenda cost can also be quite expensive! For these reasons there is a growing demand for safer ...

Saxenda (liraglutide) is a drug currently prescribed for the treatment of type 2 diabetes. A new study has demonstrated that the drug may well be useful in helping people lose weight, even if they are ...

Ozempic and its weight-loss cousin, Wegovy, outperform an earlier drug targeting the same gut hormone, a new study shows Ozempic produced 10% or more weight loss in 61% of obese people compared ...

A report by Blue Shield notes that more than half of people on weight loss medications such as Wegovy and Saxenda stop taking the drugs before they can reap the benefits ...

Researchers report that more than half of people on weight loss drugs Wegovy and Saxenda stop taking them at 12 weeks or earlier. They said that 30% of people on the drugs stop using them within ...

The weight-loss drug liraglutide (Saxenda) helped obese children lower their BMI and reach a healthier weight, researchers report.

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6, when combined with diet and exercise.

By comparison, Saxenda (liraglutide) prompted similar weight loss in only 29% of those being treated for obesity and 12% being treated for type 2 diabetes.